A Phase I/II Study of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Locally Recurrent or Metastatic Breast Cancer
K
Kathy Miller, MD
Primary Investigator
Overview
No Description Available
Description
No Description Available
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Breast Cancer, 1011004171
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
18 Apr 2024.
Study ID: 1011004171 (0805-41)
